Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $541.64 ($4.5M) on 2026-10-15, disclosed to the SEC on 2026-10-16.
Scheduled sale ($4.5M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $541.64 | 268 | $145K | 3.2% |
| 2 | $542.49 | 1,924 | $1.0M | 23.1% |
| 3 | $543.56 | 1,983 | $1.1M | 23.9% |
| 4 | $544.85 | 791 | $431K | 9.5% |
| 5 | $545.69 | 2,615 | $1.4M | 31.6% |
| 6 | $546.56 | 719 |
| $393K |
| 8.7% |
| Total | $544.30 avg | 8,300 | $4.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |